Nexilon Pharmaceutical Private Limited
About Nexilon Pharmaceutical Private Limited
Data last updated:
Nexilon Pharmaceutical Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U74999JH2019PTC012526. Its GSTIN is 20AAGCN4006L1ZS (Jharkhand).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Santosh Kumar Pandey and Ranjeet Kumar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at House No 6A New Area Gandhi Nagar Hinoo, Ranchi, Jharkhand, India – 834002.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.54 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹98,979 (net margin -9.4%) and EBITDA of ₹1.25 Lakh (EBITDA margin 11.9%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nexilon Pharmaceutical Private Limited's registered office is in Ranchi, Jharkhand. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No 6A New Area Gandhi Nagar Hinoo, Ranchi, Jharkhand, India – 834002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nexilon Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nexilon Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nexilon Pharmaceutical Private Limited, buy the company report.
Financials of Nexilon Pharmaceutical Private Limited
FY 2023 filings availableNexilon Pharmaceutical Private Limited reported revenue of ₹10.54 Lakh (down 25% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 25% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 23%. EBITDA fell 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹98,979 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.9% | ||||
| Net Profit Margin | -9.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nexilon Pharmaceutical Private Limited, buy the company report.
Board of directors of Nexilon Pharmaceutical Private Limited
Nexilon Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Kumar Pandey | Director | 08 Feb 2019 | 7 Years 8 Months | Current |
| Ranjeet Kumar | Director | 26 Aug 2022 | 4 Years 1 Months | Current |
| Tilak Bihari Also directs: Nexilon Life Sciences Private Limited | Director | 26 Aug 2022 | 4 Years 1 Months | Current |
| Munni Pandey | Director | 08 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Nexilon Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gadadhar Commercial Private Limited | ₹10.54 Lakh (FY 2024) | -18.0% | Kolkata, West Bengal, India | |||
| Syngreen Lifesciences Private Limited | ₹10.54 Lakh (FY 2025) | -71.0% | Hyderabad, Telangana, India | |||
| Marikh Life Science Private Limited | ₹10.54 Lakh (FY 2024) | 0.0% | Dhanbad, Jharkhand, India | |||
| Dan Health Care Private Limited | ₹10.54 Lakh (FY 2023) | -26.0% | Kolkata, West Bengal, India | |||
| Yash Retail and Services Private Limited | ₹10.54 Lakh (FY 2023) | -86.0% | Rewari, Haryana, India | |||
| Nexilon Pharmaceutical Private Limitedthis company | ₹10.54 Lakh (FY 2023) | -₹98,979 | -9.4% | -25.0% | Ranchi, Jharkhand, India | |
| Carlis Pharmaceuticals Private Limited | ₹10.54 Lakh (FY 2018) | -55.0% | Kota, Rajasthan, India | |||
| Yunimage Services Private Limited | ₹10.53 Lakh (FY 2021) | -98.0% | Bangalore, Karnataka, India | |||
| Tripod Textile Exports Private Limited | ₹10.53 Lakh (FY 2025) | 38.0% | Mumbai, Maharashtra, India | |||
| Kisan Srushti Private Limited | ₹10.53 Lakh (FY 2021) | Latur, Maharashtra, India | ||||
| Nisarga Life Style Marketing Private Limited | ₹10.53 Lakh (FY 2023) | 890.0% | Huliyar, Karnataka, India |
To see the full peer comparison of Nexilon Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nexilon Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nexilon Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nexilon Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAGCN4006L1ZS | Jharkhand | Active | 30 Mar 2019 |
To see the full GST registrations and return filing status of Nexilon Pharmaceutical Private Limited, buy the company report.
Recent activity
Nexilon Pharmaceutical Private Limited has 4 board changes on record since 2019: 4 appointments. The latest: Ranjeet Kumar was appointed as Director on 26 Aug 2022.
Frequently asked questions
Nexilon Pharmaceutical is an active private limited company based in Ranchi, Jharkhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 February 2019 (7+ years old) and is registered under CIN U74999JH2019PTC012526.
Nexilon Pharmaceutical has 4 current directors:
- Santosh Kumar Pandey - Director
- Ranjeet Kumar - Director
- Tilak Bihari - Director
- Munni Pandey - Director
The latest financial statements of Nexilon Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Nexilon Pharmaceutical is 20AAGCN4006L1ZS, registered in Jharkhand.
The CIN (Corporate Identification Number) of Nexilon Pharmaceutical is U74999JH2019PTC012526. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexilon Pharmaceutical was incorporated on 08 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Nexilon Pharmaceutical by revenue are Gadadhar Commercial Private Limited, Syngreen Lifesciences Private Limited, Marikh Life Science Private Limited, Dan Health Care Private Limited, Yash Retail and Services Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ranjeet Kumar was appointed as Director on 26 Aug 2022. Tilak Bihari was appointed as Director on 26 Aug 2022. Munni Pandey was appointed as Director on 08 Feb 2019. Nexilon Pharmaceutical has 4 board changes on record in total.
The registered office of Nexilon Pharmaceutical is at House No 6A New Area Gandhi Nagar Hinoo, Ranchi, Jharkhand, India – 834002.
Nexilon Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Nexilon Pharmaceutical is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.